150 related articles for article (PubMed ID: 7707492)
1. Plasma concentrations and therapeutic efficacy of phenylbutazone and flunixin meglumine in the horse: pharmacokinetic/pharmacodynamic modelling.
Toutain PL; Autefage A; Legrand C; Alvinerie M
J Vet Pharmacol Ther; 1994 Dec; 17(6):459-69. PubMed ID: 7707492
[TBL] [Abstract][Full Text] [Related]
2. Phenylbutazone and flunixin meglumine used singly or in combination in experimental lameness in horses.
Foreman JH; Ruemmler R
Equine Vet J Suppl; 2011 Nov; (40):12-7. PubMed ID: 22082440
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and anti-inflammatory effects of flunixin meglumine as a sole agent and in combination with phenylbutazone in exercised Thoroughbred horses.
Knych HK; Arthur RM; McKemie DS; Baden RW; Seminoff K; Kass PH
Equine Vet J; 2021 Jan; 53(1):102-116. PubMed ID: 32145701
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic studies of flunixin meglumine and phenylbutazone in plasma, exudate and transudate in sheep.
Cheng Z; McKeller Q; Nolan A
J Vet Pharmacol Ther; 1998 Aug; 21(4):315-21. PubMed ID: 9731955
[TBL] [Abstract][Full Text] [Related]
5. Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horses.
Reed SK; Messer NT; Tessman RK; Keegan KG
Am J Vet Res; 2006 Mar; 67(3):398-402. PubMed ID: 16506899
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of single-dose intravenous phenylbutazone and flunixin meglumine before, during and after exercise in an experimental reversible model of foot lameness in horses.
Foreman JH; Grubb TL; Inoue OJ; Banner SE; Ball KT
Equine Vet J Suppl; 2010 Nov; (38):601-5. PubMed ID: 21059067
[TBL] [Abstract][Full Text] [Related]
7. Determination of an effective dose of eltenac and its comparison with that of flunixin meglumine in horses after experimentally induced carpitis.
Hamm D; Turchi P; Johnson JC; Lockwood PW; Thompson KC; Katz T
Am J Vet Res; 1997 Mar; 58(3):298-302. PubMed ID: 9055978
[TBL] [Abstract][Full Text] [Related]
8. Effects of concurrent administration of phenylbutazone and flunixin meglumine on pharmacokinetic variables and in vitro generation of thromboxane B2 in mares.
Semrad SD; Sams RA; Harris ON; Ashcraft SM
Am J Vet Res; 1993 Nov; 54(11):1901-5. PubMed ID: 8291770
[TBL] [Abstract][Full Text] [Related]
9. Effect of probenecid on the pharmacokinetics of flunixin meglumine and phenylbutazone in healthy mares.
Zertuche JM; Brown MP; Gronwall R; Merritt K
Am J Vet Res; 1992 Mar; 53(3):372-4. PubMed ID: 1595963
[TBL] [Abstract][Full Text] [Related]
10. Measurement of cyclooxygenase inhibition in vivo: a study of two non-steroidal anti-inflammatory drugs in sheep.
Cheng Z; Nolan AM; McKellar QA
Inflammation; 1998 Aug; 22(4):353-66. PubMed ID: 9675607
[TBL] [Abstract][Full Text] [Related]
11. Use of force plate analysis to compare the analgesic effects of intravenous administration of phenylbutazone and flunixin meglumine in horses with navicular syndrome.
Erkert RS; MacAllister CG; Payton ME; Clarke CR
Am J Vet Res; 2005 Feb; 66(2):284-8. PubMed ID: 15757129
[TBL] [Abstract][Full Text] [Related]
12. The effect of inflammation on the disposition of phenylbutazone in thoroughbred horses.
Mills PC; Ng JC; Auer DE
J Vet Pharmacol Ther; 1996 Dec; 19(6):475-81. PubMed ID: 8971677
[TBL] [Abstract][Full Text] [Related]
13. Effects of Firocoxib, Flunixin Meglumine, and Phenylbutazone on Platelet Function and Thromboxane Synthesis in Healthy Horses.
Burkett BN; Thomason JM; Hurdle HM; Wills RW; Fontenot RL
Vet Surg; 2016 Nov; 45(8):1087-1094. PubMed ID: 27731498
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of the enzymes responsible for the metabolism of the non-steroidal anti-inflammatory drugs, flunixin meglumine and phenylbutazone, in horses.
Knych HK; Finno CJ; Baden R; Arthur RM; McKemie DS
J Vet Pharmacol Ther; 2021 Jan; 44(1):36-46. PubMed ID: 32757313
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic-pharmacodynamic relationships and dose response to meloxicam in horses with induced arthritis in the right carpal joint.
Toutain PL; Cester CC
Am J Vet Res; 2004 Nov; 65(11):1533-41. PubMed ID: 15566092
[TBL] [Abstract][Full Text] [Related]
16. Dose titration of the clinical efficacy of intravenously administered flunixin meglumine in a reversible model of equine foot lameness.
Foreman JH; Bergstrom BE; Golden KS; Roark JJ; Coren DS; Foreman CR; Schumacher SA
Equine Vet J Suppl; 2012 Dec; (43):17-20. PubMed ID: 23447872
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the anti-inflammatory actions of flunixin and ketoprofen in horses applying PK/PD modelling.
Landoni MF; Lees P
Equine Vet J; 1995 Jul; 27(4):247-56. PubMed ID: 8536660
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of administration of phenylbutazone alone or concurrent administration of phenylbutazone and flunixin meglumine to alleviate lameness in horses.
Keegan KG; Messer NT; Reed SK; Wilson DA; Kramer J
Am J Vet Res; 2008 Feb; 69(2):167-73. PubMed ID: 18241011
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro.
Johnstone IB
Can J Comp Med; 1983 Apr; 47(2):172-9. PubMed ID: 6883184
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and bioequivalence of two suxibuzone oral dosage forms in horses.
Jaraiz V; Rodriguez C; San Andres MD; Gonzalez F; San Andres MI
J Vet Pharmacol Ther; 1999 Aug; 22(4):247-54. PubMed ID: 10499236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
